Clinical Trial Update: Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFIRI-AD in metastatic colorectal cancer with UGT1A genotype 1; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRI-AD
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN